Resources/
Phil Blog
Phil Blog
Meet Maria Klagos, VP People Operations at PHIL
In our latest employee spotlight, we sit down with Maria Klagos, our new Head of People, who brings a wealth of experience in scaling HR functions at high-growth startups. We explore her unique background, her vision for PHIL’s culture, and the personal experiences that have shaped her professional journey. Please tell us a little bit about yourself and your new role at PHIL I joined PHIL as the VP of People Operations this past May
Is your Patient Access Hub a Strategic Partner?
By Kelly Green, Vice President of Client Success at Phil, Inc. For patients prescribed a specialty or specialty-lite medication, getting started and staying on that therapy is typically a complex and expensive journey. That’s why many life science brands are increasingly turning to hub providers to support patient access and affordability
Meet Chris Sweitzer, VP of Business Development at PHIL
In this employee spotlight interview, we are excited to feature Chris Sweitzer, our new Vice President of Business Development at PHIL. With two decades of experience in the healthcare industry and a passion for enhancing patient access, Chris brings a wealth of knowledge and a unique perspective to our team. Please tell us a little bit about yourself and your role at PHIL
8 Strategies to Decrease Prescription Abandonment and Improve Medication Adherence
An estimated 1 in 5 prescriptions are left at the pharmacy counter. This vexing healthcare challenge, known as prescription abandonment, is part of the broader concern of medication non-adherence, which also includes not taking medications as prescribed or failing to refill prescriptions. The issue is so prevalent that the American Medical Association (AMA) advises healthcare providers to "consider medication non-adherence first as a reason a patient's condition is not under control." Consequences of Prescription Abandonment Failure to stick with prescribed therapy is a substantial obstacle to a providers’ ability to deliver good patient outcomes and realize the value of pharmaceutical innovation
Meet Jwalanta Shrestha, Director of Engineering, Data and Infrastructure, at Phil
We recently caught up with Jwalanta Shrestha, our Director of Engineering, Data and Infrastructure, to get a behind-the-scenes look at his role in ensuring patients and our manufacturer partners have the right data when they need it. Please tell us about your time with Phil and your current Director of Engineering, Data, and Infrastructure role. I currently lead two different teams at Phil
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
